Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Lemaitre Vascular (LMAT) EBT Margin (2016 - 2025)

Lemaitre Vascular (LMAT) has disclosed EBT Margin for 16 consecutive years, with 48.47% as the latest value for Q4 2025.

  • On a quarterly basis, EBT Margin fell 7364.0% to 48.47% in Q4 2025 year-over-year; TTM through Dec 2025 was 9.59%, a 1627.0% decrease, with the full-year FY2025 number at 9.49%, down 1637.0% from a year prior.
  • EBT Margin was 48.47% for Q4 2025 at Lemaitre Vascular, down from 37.48% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 37.48% in Q3 2025 to a low of 53.28% in Q4 2023.
  • A 5-year average of 15.27% and a median of 20.66% in 2023 define the central range for EBT Margin.
  • Peak YoY movement for EBT Margin: skyrocketed 7844bps in 2024, then crashed -7364bps in 2025.
  • Lemaitre Vascular's EBT Margin stood at 19.67% in 2021, then fell by -3bps to 19.04% in 2022, then crashed by -380bps to 53.28% in 2023, then skyrocketed by 147bps to 25.16% in 2024, then tumbled by -293bps to 48.47% in 2025.
  • Per Business Quant, the three most recent readings for LMAT's EBT Margin are 48.47% (Q4 2025), 37.48% (Q3 2025), and 28.13% (Q2 2025).